ArticleEndocrine2022

Continuous glucose monitoring and 1-h plasma glucose identifies glycemic variability and dysglycemia in high-risk individuals with HbA1c < 5.7%: a pilot study.

Brenda Dorcely et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.